BACKGROUND: Atrial fibrillation (AF) is increasingly prevalent in elderly patients and adversely affects clinical outcomes after coronary artery bypass grafting, non-cardiac surgery or myocardial infarction. Aim of the present analysis was to investigate the prognostic impact of AF in patients undergoing drug eluting stent (DES) implantation during a 1-year follow-up. PATIENTS AND METHODS: 5,772 consecutive patients undergoing percutaneous coronary intervention were enrolled into the German Drug Eluting Stent Registry (DES.DE) and were followed for 12 months. Of these 455 had AF and 5,317 in sinus rhythm served as controls. Univariate and multivariate logistic regression analyses were used to determine the risk of major adverse cardiac and cerebrovascular events (MACCE) and bleeding complications. RESULTS: Patients with AF were older (71.3 ± 7.6 vs. 64.7 ± 10.5 years) and had a higher prevalence of diabetes, hypertension, renal insufficiency as well as more prior bypass surgery, stroke and peripheral arterial disease. Cardiogenic shock (2.9 vs. 1.4 %; p < 0.05), left ventricular ejection fraction ≤40 % (21.0 vs. 11.4 %; p < 0.0001) and triple vessel disease (44.4 vs. 37.9 %; p < 0.01) were more frequent in patients with AF than in controls. MACCE (OR 2.08, 95 % CI 1.56-2.77), total mortality (OR 3.27, 95 % CI 2.32-4.62) and non-fatal stroke (OR 2.03, 95 % CI 1.03-4.00) as well as bleeding complications (OR 1.88, 95 % CI 1.13-3.12) during the 1-year follow-up were more frequent in patients with AF (univariate analysis). In multivariate analyses adjusting for covariates determined to be relevant at baseline, the risk for total mortality remained elevated (OR 1.63, 95 % CI 1.05-2.52). CONCLUSIONS: AF is an important predictor of long-term mortality in patients undergoing DES implantation.
BACKGROUND:Atrial fibrillation (AF) is increasingly prevalent in elderly patients and adversely affects clinical outcomes after coronary artery bypass grafting, non-cardiac surgery or myocardial infarction. Aim of the present analysis was to investigate the prognostic impact of AF in patients undergoing drug eluting stent (DES) implantation during a 1-year follow-up. PATIENTS AND METHODS: 5,772 consecutive patients undergoing percutaneous coronary intervention were enrolled into the German Drug Eluting Stent Registry (DES.DE) and were followed for 12 months. Of these 455 had AF and 5,317 in sinus rhythm served as controls. Univariate and multivariate logistic regression analyses were used to determine the risk of major adverse cardiac and cerebrovascular events (MACCE) and bleeding complications. RESULTS:Patients with AF were older (71.3 ± 7.6 vs. 64.7 ± 10.5 years) and had a higher prevalence of diabetes, hypertension, renal insufficiency as well as more prior bypass surgery, stroke and peripheral arterial disease. Cardiogenic shock (2.9 vs. 1.4 %; p < 0.05), left ventricular ejection fraction ≤40 % (21.0 vs. 11.4 %; p < 0.0001) and triple vessel disease (44.4 vs. 37.9 %; p < 0.01) were more frequent in patients with AF than in controls. MACCE (OR 2.08, 95 % CI 1.56-2.77), total mortality (OR 3.27, 95 % CI 2.32-4.62) and non-fatal stroke (OR 2.03, 95 % CI 1.03-4.00) as well as bleeding complications (OR 1.88, 95 % CI 1.13-3.12) during the 1-year follow-up were more frequent in patients with AF (univariate analysis). In multivariate analyses adjusting for covariates determined to be relevant at baseline, the risk for total mortality remained elevated (OR 1.63, 95 % CI 1.05-2.52). CONCLUSIONS:AF is an important predictor of long-term mortality in patients undergoing DES implantation.
Authors: S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith Journal: Circulation Date: 2001-06-19 Impact factor: 29.690
Authors: S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon Journal: Circulation Date: 2000-03-07 Impact factor: 29.690
Authors: Michael C Nguyen; Yean L Lim; Antony Walton; Jeffrey Lefkovits; Giancarlo Agnelli; Shaun G Goodman; Andrzej Budaj; Dietrich C Gulba; Jeanna Allegrone; David Brieger Journal: Eur Heart J Date: 2007-06-11 Impact factor: 29.983
Authors: Lars Køber; Karl Swedberg; John J V McMurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf Journal: Eur J Heart Fail Date: 2006-02-28 Impact factor: 15.534
Authors: Timm Bauer; Christoph A Nienaber; Ibrahim Akin; Karl-Heinz Kuck; Matthias Hochadel; Jochen Senges; Thomas Fetsch; Ulrich Tebbe; Stefan N Willich; Jürgen Stumpf; Georg V Sabin; Sigmund Silber; Gert Richardt; Ralf Zahn Journal: Clin Res Cardiol Date: 2011-03-18 Impact factor: 5.460
Authors: Mohammad A Sherif; Christoph A Nienaber; Ralph Toelg; Mohamed Abdel-Wahab; Volker Geist; Steffen Schneider; Jochen Senges; Karl-Heinz Kuck; Ulrich Tebbe; Gert Richardt Journal: Clin Res Cardiol Date: 2010-12-01 Impact factor: 5.460
Authors: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs Journal: Circulation Date: 2004-08-31 Impact factor: 29.690
Authors: Roxana Mehran; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; S Chiu Wong; Eugenia Nikolsky; Louise Gambone; Lynn Vandertie; Helen Parise; George D Dangas; Gregg W Stone Journal: Lancet Date: 2009-08-28 Impact factor: 79.321
Authors: Gregory Y H Lip; Kurt Huber; Felicita Andreotti; Harald Arnesen; K Juhani Airaksinen; Thomas Cuisset; Paulus Kirchhof; Francisco Marín Journal: Thromb Haemost Date: 2009-09-30 Impact factor: 5.249
Authors: Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger Journal: Eur Heart J Date: 2009-06-06 Impact factor: 29.983
Authors: I Akin; C Naber; G Sabin; M Hochadel; J Senges; K H Kuck; C Nienaber; G Richardt; Ralph Tölg Journal: Clin Res Cardiol Date: 2013-05-17 Impact factor: 5.460
Authors: Tadeusz Osadnik; Jarosław Wasilewski; Andrzej Lekston; Joanna Strzelczyk; Anna Kurek; Aleksander Rafał Gutowski; Krzysztof Dyrbuś; Kamil Bujak; Rafał Reguła; Piotr Rozentryt; Bożena Szyguła-Jurkiewicz; Lech Poloński Journal: Clin Res Cardiol Date: 2014-03-09 Impact factor: 5.460
Authors: Jens Wiebe; Helge Möllmann; Astrid Most; Oliver Dörr; Kay Weipert; Johannes Rixe; Christoph Liebetrau; Albrecht Elsässer; Stephan Achenbach; Christian Hamm; Holger Nef Journal: Clin Res Cardiol Date: 2013-10-18 Impact factor: 5.460